Studies provide insights into COVID vaccine hesitancy


Two JAMA Network Open studies yesterday that looked at COVID-19 vaccine acceptance in minority groups and opinions around less-preferred vaccines provide clues for how officials might better encourage immunization.

The first study, involving 13 focus groups, reaffirmed a lack of communication and trust among racially and ethnically diverse communities in the United States.

The second study examined the effect of emphasizing different data around the Johnson & Johnson and AstraZeneca/Oxford COVID-19 vaccines: People were more interested in uptake when they were presented with the vaccines’ effectiveness against death versus their effectiveness against symptomatic infection.

Concerns about trust, unequal treatment

The virtual focus groups involved 70 Los Angeles residents from Nov 16, 2020, to Jan 28, 2021. (Pfizer/BioNTech, the first emergency-use approved vaccine in the United States, received its emergency-use authorization in mid-December 2020.)



read the full story